Cargando…
Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice
Type 1 diabetes (T1D) is a metabolic disease characterized by hyperglycemia and can affect multiple organs, leading to life-threatening complications. Increased prevalence of pulmonary disease is observed in T1D patients, and diabetes is a leading cause of comorbidity in several lung pathologies. A...
Autores principales: | Park, Sangmi S., Mai, Michelle, Ploszaj, Magdalena, Cai, Huchong, McGarvey, Lucas, Mueller, Christian, Garcia-Arcos, Itsaso, Geraghty, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566687/ https://www.ncbi.nlm.nih.gov/pubmed/37819895 http://dx.doi.org/10.1371/journal.pone.0291948 |
Ejemplares similares
-
Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus
por: Park, Sangmi S., et al.
Publicado: (2021) -
CELA1 Mediates Progressive Emphysema in Alpha-1 Antitrypsin Deficiency
por: Devine, Andrew J., et al.
Publicado: (2023) -
Basilar Predominant Emphysema: Thinking beyond Alpha-1-Antitrypsin Deficiency
por: Yeung, Ho-Man, et al.
Publicado: (2022) -
Identifying Alpha-1 Antitrypsin Deficiency Based on Computed Tomography Evidence of Emphysema
por: Miskoff, Jeffrey A, et al.
Publicado: (2019) -
Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency
por: Perotin, Jeanne Marie, et al.
Publicado: (2018)